HRT FORMULIERUNGEN

European patent · EP1670440 · Deleted

Register entry

Publication number
EP1670440
Application number
EP04762858
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 21, 2004
Published
Jun 21, 2006
Granted
Apr 30, 2014
Deleted
Nov 8, 2023
Reason
Revoked in opposition
IPC classes
A61K 31/56 (2006.01)
A61K 31/57 (2006.01)
A61K 9/20 (2006.01)
Priority
DK 200301408 29.09.2003
US 509962 P 09.10.2003
DK 200301828 10.12.2003
US 536121 P 13.01.2004
PCT application
PCT/DK2004/000638 21.09.2004
PCT publication
WO2005/030175 07.04.2005
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 9, 2023

    Change

    Published in Swissreg on 09.11.2023

  2. Apr 17, 2019

    Deleted, fee unpaid

    Published in Swissreg on 17.04.2019

  3. Jun 16, 2015

    Agent entered

    Representative
    R.A. Egli & Co, Patentanwälte, Baarerstrasse 14, 6300 Zug

    Published in Swissreg on 16.06.2015

  4. Jun 16, 2015

    Transferred

    Owner
    Novo Nordisk Femcare AG, Andreastrasse 15, 8050 Zürich → Novo Nordisk Health Care AG, Thurgauerstrasse 36/38, 8050 Zürich

    Published in Swissreg on 16.06.2015

  5. Apr 30, 2014

    Granted

    Published in Swissreg on 30.04.2014

Parties

Holder

Novo Nordisk Health Care AG

Thurgauerstrasse 36/38, 8050 Zürich

Agent

R.A. Egli & Co, Patentanwälte

Baarerstrasse 14, 6300 Zug

Inventor

EDWARDS, WILLIAM, Martin

Medstead, Hants GU34 5JF, GB

SHALMI, Michael

2900 Hellerup, DK

JENSEN, MOLLER, Bente

2630 Taastrup, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.